Paroxysmal Nocturnal Hemoglobinuria Following Alemtuzumab Immunosuppressive Therapy for Myelodysplastic Syndrome and Complicated by Recurrent Life-threatening Thrombosis Despite Anticoagulation: Successful Intervention with Eculizumab And...

Overview

Journal Leuk Res

Date 2009 Oct 20

PMID 19836075

Citations 3

Authors

Kit L Cheng

Judith Brody

Craig E Warshall

Elaine M Sloand

Steven L Allen

Affiliations

Soon will be listed here.

Citing Articles

The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Alashkar F, Schemuth H, Nensa F, Gobel J, Vance C, Forsting M Sci Rep. 2018; 8(1):13458.

PMID: 30194314 PMC: 6128936. DOI: 10.1038/s41598-018-31547-7.

Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial.

Kanakura Y, Ohyashiki K, Shichishima T, Okamoto S, Ando K, Ninomiya H Int J Hematol. 2013; 98(4):406-16.

PMID: 23934275 DOI: 10.1007/s12185-013-1404-y.

[Alemtuzumab: a further option for treatment of multiple sclerosis].

Menge T, Kieseier B, Warnke C, Aktas O, Hartung H Nervenarzt. 2011; 83(4):487-501.

PMID: 22038387 DOI: 10.1007/s00115-011-3393-5.

References

Garland R, Groves S, Diamanti P, West S, Winship K, Virgo P . Early emergence of PNH-like T cells after allogeneic stem cell transplants utilising CAMPATH-1H for T cell depletion. Bone Marrow Transplant. 2005; 36(3):237-44. DOI: 10.1038/sj.bmt.1705049. View

Ruiz P, Weppler D, Tryphonopoulos P, Nishida S, Moon J, Kato T . CD55 and CD59 deficiency in transplant patient populations: possible association with paroxysmal nocturnal hemoglobinuria-like symptoms in Campath-treated patients. Transplant Proc. 2006; 38(6):1750-2. DOI: 10.1016/j.transproceed.2006.05.018. View

Meletis J, Terpos E, Samarkos M, Meletis C, Apostolidou E, Komninaka V . Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes. Hematol J. 2002; 2(1):33-7. DOI: 10.1038/sj.thj.6200077. View

Rother R, Bell L, Hillmen P, Gladwin M . The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005; 293(13):1653-62. DOI: 10.1001/jama.293.13.1653. View

Warkentin T, Maurer B, Aster R . Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med. 2007; 356(25):2653-5. DOI: 10.1056/NEJMc070346. View